Skip to content
Screener

Geron GERN Product revenue, net — Total revenues

Other product segments

Gross product revenue
$72.44M+25.2%
Chargebacks
-$9.19M
Distributor service fees
-$2.37M
Government rebates
-$1.97M-329%
Sales returns and allowances
-$1.43M-177%

Similar metrics at other companies

Rhythm Pharmaceuticals, Inc. logo
RYTMProduct revenue, net — Total revenues
$60.11M+59.4%
Kinetik Holdings logo
KNTKProduct revenue — Total revenues
$312.23M-0.1%
Quanterix Corporation logo
QTRXProduct revenue — Total revenues
$23.48M+39.5%
Cactus logo
WHDProduct revenue — Total revenues
$297.24M+42.2%
Ardelyx logo
ARDXProduct supply revenue — Total revenues
$1.98M-68.1%
ALN
ALNYNet product revenues — Total revenues
$1.17B+74.4%

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Operating income-$12.5M-0.3%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$1.01B+13.8%
Enterprise value$1.08B+14.5%
P/S4.9×-180×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
Line itemTHREE MONTHS ENDEDJUNE 30, 2026THREE MONTHS ENDEDJUNE 30, 2025SIX MONTHS ENDEDJUNE 30, 2026SIX MONTHS ENDEDJUNE 30, 2025
Revenues:
Product revenue, net$57,473$49,007$109,244$88,443
Royalties72973196
Total revenues57,48049,036109,31788,639
Costs and operating expenses:
Cost of goods sold9,2401,19010,9322,396
Research and development22,03021,73636,98636,814
Selling, general and administrative38,86338,56474,28878,587

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's product revenue, net — total revenues?
Geron (GERN) reported product revenue, net — total revenues of $57.47M in Q2 2026.
How has Geron's product revenue, net — total revenues changed year-over-year?
Geron's product revenue, net — total revenues increased by 17.3% year-over-year, from $49.01M to $57.47M.
What does product revenue, net — total revenues mean?
This metric represents the net revenue generated specifically from the commercial sale of pharmaceutical products, excluding income from licensing, milestones, or collaboration agreements. It serves as a key indicator of the company's transition from a clinical-stage research entity to a commercial-stage business. Tracking this figure allows investors to assess the market adoption and revenue-generating potential of the company's core therapeutic assets.

Ask your AI about Geron's product revenue, net — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude